Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR-Preserved trial.
Packer, Milton;
Zannad, Faiez;
Butler, Javed;
Filippatos, Gerasimos;
Ferreira, Joao Pedro;
Pocock, Stuart J;
Brueckmann, Martina;
Zeller, Cordula;
Hauske, Sibylle;
Anker, Stefan D;
+1 more...EMPEROR-Preserved Trial Study Group;
EMPEROR-Preserved Trial Study Group;
(2021)
Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR-Preserved trial.
European journal of heart failure, 23 (10).
pp. 1798-1799.
ISSN 1388-9842
DOI: https://doi.org/10.1002/ejhf.2334
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
